SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 15, 2003
----------------------------------------------------------------
IMS HEALTH INCORPORATED
-----------------------
(Exact name of registrant as specified in its charter)
Delaware 001-14049 06-1506026
---------------------------------------------------------------------
(State of (Commission File Number) (IRS Employer
incorporation) Identification No.)
1499 Post Road
Fairfield, Connecticut 06824
----------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(203) 319-4700
--------------
(Registrant's telephone number,
including area code)
N/A
(Former name or former address, if changed since last report)
Item 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Financial Statements.
None
(b) Pro Forma Financial Information.
None
(c) Exhibits.
The following exhibit is furnished as part of this report:
Exhibit Number Description
-------------- -----------
99.1 Press Release dated April 15, 2003.
Item 9. REGULATION FD DISCLOSURE
In accordance with guidance from the Securities and Exchange
Commission in Release number 33-8216, the information furnished under this
Item 9 ("Regulation FD Disclosure") is intended to be furnished under Item 12
("Results of Operations and Financial Condition"). In accordance with General
Instruction B.6 of Form 8-K, the information in this Current Report on Form
8-K, including Exhibit 99.1, shall not be deemed "filed" for the purpose of
Section 18 of the Securities and Exchange Act of 1934 or otherwise subject to
the liability of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933.
On April 15, 2003, IMS Health Incorporated (the "Company") issued a
press release regarding financial results for its first quarter of fiscal
2003, ending March 31, 2003. A copy of this press release is being furnished
as Exhibit 99.1 to this Current Report on Form 8-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
IMS HEALTH INCORPORATED
By: /s/ Robert H. Steinfeld
------------------------------
Name: Robert H. Steinfeld
Title: Senior Vice President, General Counsel
and Corporate Secretary
Date: April 15, 2003
EXHIBIT INDEX
Exhibit Number Description
-------------- -----------
99.1 Press Release dated April 15, 2003.